Cidara, which issued a 7.7% stake to Seachaid Pharmaceuticals last year, floated at the top of its range, raising $76.8m in the process.

Ortho Kinematics secured $9.6m in the round, raised as it prepares to commercialise its radiographic spinal imaging system in Europe and the US.

Existing shareholder Johnson & Johnson will buy $30m of stock in the cancer treatment developer as part of the offering.

ReCor Medical raised the money in a series D round led by healthcare group Otsuka Holdings that will support a trial study for its hypertension treatment device.

The Netherlands-based oncology company, backed by corporate venturing subsidiaries of Johnson & Johnson, Novartis and Pfizer, plans to float in the US later this year.

Prescription platform ZappRx has raised $5.6m in a series A round that has taken its overall funding to almost $9m.

Celgene and Eli Lilly are putting up $140m of the $150m available for Early-Stage Life Sciences Funding Initiative, which will fund New York biotech startups.

Y Combinator startup PicnicHealth secures $2m seed from consortium including Stanford StartX fund to make health records more accessible.